HD-OPM Archive
Topics › Aging & longevity

Metformin may slow multiple sclerosis symptoms; evidence mostly from animals and labs

Louis Nervegna · Mar 24, 2026 · ♥ 8 reactions · 2 comments · original Facebook post
Aging & longevityInsulin resistance & diabetes
AI summary & key facts

Louis shares a report that metformin boosts the energy of myelin-repairing cells, which may help regenerate nerve insulation lost in multiple sclerosis. Most evidence is from animal and laboratory work, with early clinical hints.

Metformin might slow, or even reverse, symptoms of multiple sclerosis.

#metforminHD #msHD

Research cited

A recent article from ScienceNews highlights a surprising new potential use for metformin, a common diabetes drug.
Researchers suggest that metformin may help slow—or even reverse—symptoms of multiple sclerosis (MS).
The key mechanism appears to be its effect on cells responsible for repairing myelin, the protective layer around nerves.
By boosting the energy of these cells, metformin may improve their ability to regenerate damaged nerve insulation.
This is significant because loss of myelin is a central problem in MS, leading to neurological symptoms.
Most of the current evidence comes from animal and laboratory studies, where promising results have been observed.
There are also early clinical trials exploring metformin’s role in human MS patients.
Beyond regeneration, metformin may also reduce inflammation, which plays a major role in disease progression.
However, scientists caution that more research is needed before it can be used as a standard MS treatment.
Still, this discovery opens an exciting new direction in the search for therapies that don’t just slow MS—but potentially repair damage.

← newer: Six randomized diet trials have shown plaque reversal, and solder: Yassine: Swedish APOE4 meat study underpowered for dementia →